陳冠廷(チンカンテイ)
    • Create new note
    • Create a note from template
      • Sharing URL Link copied
      • /edit
      • View mode
        • Edit mode
        • View mode
        • Book mode
        • Slide mode
        Edit mode View mode Book mode Slide mode
      • Customize slides
      • Note Permission
      • Read
        • Only me
        • Signed-in users
        • Everyone
        Only me Signed-in users Everyone
      • Write
        • Only me
        • Signed-in users
        • Everyone
        Only me Signed-in users Everyone
      • Engagement control Commenting, Suggest edit, Emoji Reply
    • Invite by email
      Invitee

      This note has no invitees

    • Publish Note

      Share your work with the world Congratulations! 🎉 Your note is out in the world Publish Note

      Your note will be visible on your profile and discoverable by anyone.
      Your note is now live.
      This note is visible on your profile and discoverable online.
      Everyone on the web can find and read all notes of this public team.
      See published notes
      Unpublish note
      Please check the box to agree to the Community Guidelines.
      View profile
    • Commenting
      Permission
      Disabled Forbidden Owners Signed-in users Everyone
    • Enable
    • Permission
      • Forbidden
      • Owners
      • Signed-in users
      • Everyone
    • Suggest edit
      Permission
      Disabled Forbidden Owners Signed-in users Everyone
    • Enable
    • Permission
      • Forbidden
      • Owners
      • Signed-in users
    • Emoji Reply
    • Enable
    • Versions and GitHub Sync
    • Note settings
    • Note Insights New
    • Engagement control
    • Make a copy
    • Transfer ownership
    • Delete this note
    • Save as template
    • Insert from template
    • Import from
      • Dropbox
      • Google Drive
      • Gist
      • Clipboard
    • Export to
      • Dropbox
      • Google Drive
      • Gist
    • Download
      • Markdown
      • HTML
      • Raw HTML
Menu Note settings Note Insights Versions and GitHub Sync Sharing URL Create Help
Create Create new note Create a note from template
Menu
Options
Engagement control Make a copy Transfer ownership Delete this note
Import from
Dropbox Google Drive Gist Clipboard
Export to
Dropbox Google Drive Gist
Download
Markdown HTML Raw HTML
Back
Sharing URL Link copied
/edit
View mode
  • Edit mode
  • View mode
  • Book mode
  • Slide mode
Edit mode View mode Book mode Slide mode
Customize slides
Note Permission
Read
Only me
  • Only me
  • Signed-in users
  • Everyone
Only me Signed-in users Everyone
Write
Only me
  • Only me
  • Signed-in users
  • Everyone
Only me Signed-in users Everyone
Engagement control Commenting, Suggest edit, Emoji Reply
  • Invite by email
    Invitee

    This note has no invitees

  • Publish Note

    Share your work with the world Congratulations! 🎉 Your note is out in the world Publish Note

    Your note will be visible on your profile and discoverable by anyone.
    Your note is now live.
    This note is visible on your profile and discoverable online.
    Everyone on the web can find and read all notes of this public team.
    See published notes
    Unpublish note
    Please check the box to agree to the Community Guidelines.
    View profile
    Engagement control
    Commenting
    Permission
    Disabled Forbidden Owners Signed-in users Everyone
    Enable
    Permission
    • Forbidden
    • Owners
    • Signed-in users
    • Everyone
    Suggest edit
    Permission
    Disabled Forbidden Owners Signed-in users Everyone
    Enable
    Permission
    • Forbidden
    • Owners
    • Signed-in users
    Emoji Reply
    Enable
    Import from Dropbox Google Drive Gist Clipboard
       Owned this note    Owned this note      
    Published Linked with GitHub
    • Any changes
      Be notified of any changes
    • Mention me
      Be notified of mention me
    • Unsubscribe
    # **Biochemistry** midterm exam includes: **lipids** and its **catabolism, synthesis** **cholestrol** and **lipoprotein** **degration, synthesis** of amino acid **heme** ## wk1. lipids ![](https://i.imgur.com/KzWOWrq.png) * all biological lipids are amphipathic. * common function of lipids: membrane, storage, messenger, protection, insultation (nerve transmition) * membrane lipids: glycolipids (including sphingolipids), phospholipids * storage lipids: fatty acid, triacylglycerol * messenger: glycerophospholipids and sphingolipids acts locally while steroid act remotely as hormones * protection: from water loss and physical shock ### 1.fatty acid ![](https://i.imgur.com/pD4Nhba.png) >catorized in 3 ways with/without double bond: saturated/unsaturated configuration of duble bond: trans/cis > >saturated FA has higher m.p. and trans FA has higher m.p. if other condition ctrl. > >omega >omega indicate where the first double bond appreas. >the omega-3 fatty acid means that: >from the end of the chain, the third carbon has double bond. >carbon number >e.g., C18:3 means that the chain includes 18 carbons and 3 double bonds. >some important saturated acid >|common name|numeric| >| -:| -:| >|butyric acid|4:0| >|lauric acid|12:0| >|myristic acid|14:0| >|palmitic acid (PA)|16:0| >|stearic acid (SA)|18:0| >some **essential** FA >|common name|numeric|omega| >| -:| -:| -:| >|oleic acid (OA)|18:1|omega-9| >|**linoleic acid (LA)**|18:2|omega-6| >|**alpha-linoleic acid (ALA)**|18:3|omega-3| >|gamma-linoletic acid (GLA)|18:3|omega-6| >|**arachidonic acid (AA)**|20:4|omega-6| >|**eicosapentaenoic acid (EPA)**|20:5|omega-3| >|docosapentaenoic acid (DPA)|22:5|omega-3| >|**docosahexaeonic acid (DHA)**|22:6|omega-3| >use of FA >|catagory|function| >|-|-| >|omega-3|cardio-protective, anti-inflammatory, anti-carcinogenic| >|omega-6|protaglandins, thromboxanes, leukotrienes syn.| ### 2.Triacylglycerols >some facts: >* compose of glycerol and 3 fatty acid >* does not need a solvent >* carbon is more reduced so that it's more efficient >* oxidation of TG can produce water ### 3.Glycerophospholipids ![](https://i.imgur.com/R23DSc2.png) >* compose of glycerol, 2 fatty acid and a phosphate >different kinds of glycerophospholipids >(記前三個就好) >|name|x (取代基)| >|-|-| >|phosphatidic acid (PA)|hydrogen| >|phosphatidylethanolamine (PE)|ethanolamine| >|phosphatidylserine (PC)|choline| >|phosphatidylserine (PS)|serine| >|phosphatidylglycerol (PG)|glycerol| >|phosphatidylinositol (PI)|myo-inositol-4,5-biphosphate| >|cardiolipin|very big structure| >ether lipids >one of the acyl group has an ether linkage (-OR) >(1) plasmalogens: about half of lipid in heart tissue > >![](https://i.imgur.com/8OgrqH3.png) > >(2) platelet-activating factor >responsible for: >* aggregation of platelet, release of serotonin, >* regulation of inflammation/allergic response > >![](https://i.imgur.com/bAVOzNn.png) > >both the abovementioned are PC ### 4.sphingolipids >* sphingolipids include the structure of sphingosine (a 18C alcohol) >![](https://i.imgur.com/No7EJmE.png) >* the amine group links to a fatty acid >* and hydroxyl group links to other groups (see below) >* sphingolipids are sites of blood type recognition >different kinds of sphingolipids >|name|x (取代基)| >|-|-| >|ceramide|H| >|sphingomyelin|phosphocholine(磷酸膽鹼)| >|glucosylcerebroside|glucose| >|lactosylceramide|di-, tri-, tetrasaccharide| >|ganglioside GM2|complex oligosaccharide| >ceramide >* 50% of the intercellular lipids of a horned layer >* lack of ceramide may cause dry skin >spingomyelin >* form the myelin sheath in neutal system >cerebroside >* beta-glycosidic linkage >ganglioside >* oligosaccharide that made of 3 or more sugars >* and one of which is sialic acid >* muscle / nerve membrane >* nerve end, impluse transmition ![](https://i.imgur.com/HgDlpss.png) ### 5.waxes > some facts > * waxes are ester that combine long-chain fatty acid and long-chain alcohol, each 14-30 C, unbranced > * common wax sources: animal fur or feather, plant leaves, stems, fruits ### 6.isoprene-based lipids ![](https://i.imgur.com/KMMyfts.png) >* isoprene = 2-methyl-1,3-butadiene (2-甲基-1,3-二丁烯) >* one or multiple terpene froms a variety of compounds, e.g., retinal is a diterpene >coumadin (warfarin) >* when being called coumadin, it is an oft-prescribed anticoagulant >* called warfarin, it is a reodent poison >* both of the mechanism is that coumadin is an antagonist of Vit. K: > >when clotting, amino acid Glu needs to add a carboxyl group at its gama site > >![](https://i.imgur.com/1sXJpE6.png) > >Vit K. faciliates GGCX, gamaglutamic carboxylase >and by antagonising (oxdizing) Vit. K, glutamic acid will less likely attach to Ca+ >steroids >* choelsterol is the precursor of many steriods ### 7.eicosanoids >* act as **paracrine** hormones >* some notable eicosanoids: prostaglandins, prostacyclins, thromboxanes, leukotrienes, epoxyeicosatrienoic acids. ### 8.glycerophospholipid metabolism >* a phospholipid has two fatty acid chain attach to glycerol phosphate >* the enzyme that cleave two fatty acid is called phospholipase A1, A2, respectively >* the enzyme cleaves phosphate and the rest of phospholipid apart is called phospholipase C >* the enzyme cleaves the attached group and phosphate apart is called phospholipase D >![](https://i.imgur.com/ln0SYKy.png) >* phospholipid that reacted with PLA1, A2 will lose one of its fatty acid chain and be called **lysophospholipid** >* lysophospholipid looks like SDS, which is used as detergent, both of which has similar function >e.g., lysolecithin is a product of PLA2, it can dissolve membrane of RBC, causing rupture >some notable (glycero)phospholipids breakdown products: >arachidonic acid(**AA**), lysophosphatidic acid(LPA), diacylglycerol (**DAG**), inositol phosphate (IP3) ## wk2. FA catabolism ### 1. sources of TG #### 3 main sources > * chylomicrons (food intake) > * albumin (stored in adipocytes) > * VLDL particles (carbohydrate synthesis) #### process of ingestion >* in the lumen of intestine, there's villi that absorb nutrients >* the surface of villi lie enterocytes that have microvilli >* emulsification: tearing apart fats(TG) with emulsifier (e.g., bile) >* hydrolysis of TG by pancreatic and intestinal lipase >* **pancreatic** lipase cleave fatty acid at **C1 & C3** >* **intestinal** lipase, **C2** >* villi absorb the fatty acids and monoacylglycerols and regenerate TG within enterocytes >* the regenarated TG assemble with certain protein and be released to lacteal as chylomicrons #### process of fatty acid transport by albumin >* fat reservior occupy a great proportion of adipocyte >* albumin: 40mg/mL in serum, provide 80% of osmotic pressure and act as buffer solute >* free fatty acid soluability in blood is 0.1nM >* bind to serum albumin, the soluability rise to 1mM (10,000 times) >* the main receptor of FA is adipose and muscle tissue ### 2. (typical) beta oxidation * the carbon next to carboxyl group in a fatty acid is called **alpha** carbon, the next, beta, and so forth * oxidation at the bond between alpha and beta bond will produce acyl-CoA, 1 NADH and 1 FADH2 * 1 acyl-CoA will produce 3NADH, 1FADH2 and 1ATP ![](https://i.imgur.com/KXH4RJr.png) * natural antioxidants like catechins(綠茶兒茶素) can improve fatty acid oxidation and increase glycogen level in muscle cell #### step 1: esterfication with CoA-SH >* fatty acid bind to CoASH with needs 1 ATP and 1 Pyrophosphate as energy source >* the first is the "investment" stage of beta oxidation >**product: (fatty) acyl - CoA (ester)** #### step 2: membrane transportation >* fatty needs to be transport from cytosol to **Mt.**, where beta oxidation take place >* carnitine can carry "R-C=O" part of acyl-CoA,and take the group to the martix of Mt. >**midproduct: (fatty) acyl - carnitine (ester)** >* acyl carnitine ester get into a mitochondion via carrier protein and regenerate acyl-CoA >* after regeneration, carnitine get back to cytosol via the carrier protein >![](https://i.imgur.com/D7aryqk.png) #### step 3: carbon backbone reaction sequence 3-1: **dehydrogenation** >enzyme: acyl-CoA dehydorgenase = A**D** >reaction: the two hydrogen on beta carbon removed, forming a double bond between alpha and beta carbon >**product: trans-enoyl-CoA**, 1FADH2 = 1.5ATP >(有一個丙烯基在alpha跟beta中間, enoyl) >![](https://i.imgur.com/iNQSeEZ.png) 3-2: **hydration** >enzyme: enoyl-CoA hydrate = E**H** >reaction: addition of water on beta carbon >**product: 3-hydroxy acyl -CoA** >(3號碳,就是beta,上有羥基) >![](https://i.imgur.com/OKAakKy.png) 3-3: **dehydrogenation** >enzyme: 3-L-hydroxyacyl-CoA dehydrogenase = HA**D** >reaction: remove the two hydrogen and make a C=O group at beta site >**product: beta-ketoacyl-CoA** >(羥基脫水變酮) >![](https://i.imgur.com/tYM7VOg.png) 3-4: **thiolase** reaction (C-C cleavage) >enzyme: beta-ketoacyl-CoA thiolase = K**T** >reaction: cleave the bond between alpha and beta carbon >After that, adds a CoA-SH on the "former" bata carbon (esterfication) >**product: acyl-CoA and fatty acyl-CoA** >(因為在beta處,新的碳氧雙鍵做好了,那舊的就可以放心離開,變成乙醯輔酶A) >![](https://i.imgur.com/VByDmyK.png) >in step 3-1 AD (acyl-CoA dehydrogenase) has 4 varients >very long chain, long chain, medium chain, short chain >(VLCAD, LCAD, MCAD, SCAD) #### calculation a 16C fatty acid can generate: >esterfication: -2ATP >7 cleavage: 7FADH2 + 7NADH >8 acyl-CoA: 8FADH2 + 24NADH + 8ATP > >15FADH2 = 22.5ATP, 31NADH = 77.5ATP >total 22.5+77.5+8-2=106 (ATPs) > >byproduct: 123H20 ### 3. odd carbon FA oxidation * odd carbon FA generate acyl-CoA as even number carbon FA do, but in the end, it will produce **propionyl-CoA** * the goal: make propionyl-CoA to succinyl-CoA * the reaction involve Vit. B7 & B12 * **excessive** succinyl-CoA can be turned into **malate** via TCA cycle and be turned into **pyruvate** with the help of malic enzyme, which generates 1NADPH ### 4. unsaturated FA oxidation * since the structure may not be "trans" as the step 3-2 (hydration) of beta oxidation required, it needs a **enoyl-CoA isomerase** * the double bond needs to be between alpha and beta carbon, enoyl-CoA can also adjust them as step 3-2 required * if two double bond, esp. one trans one cis, are beside each other, 2,4-dienoyl-CoA reductase reduce them and form a new double bond between the "former" two ### 5. alpha oxidation * if the carbon number is excessive for beta oxdation, the oxidation of carboxylic group, which make the alpha carbon the new carboxylic group, is called alpha oxidation * after trimming by alpha oxidation, beta oxidation can generate propionyl-CoA and acyl-CoA * the enzyme involved is called phytanic acid oxidase or alpha-hydroxylase * lack of the enzyme will cause **Refsum's disease** ![](https://i.imgur.com/cGLjvna.png) ### 6. omega oxidation * omega means the farest carbon from carboxyl group * when beta oxidation within mitochondria cannot function(lack of carnitine or mutation), omega oxidation is a minor but important substitution * omega oxidation occur in **ER** * the opposite side of carboxyl group in FA is oxidize and become another carboxyl group * after the second carboxyl group formed, beta oxidation starts, producing **succinate and adipate (dicarboxylic acid, DCA)** * the reaction requires **cytochrome P450** ![](https://i.imgur.com/l4kflSb.png) ### 7. peroxisomal beta oxidation * uusally use long chain and branched FA to make heat in peroxisomes * in peroxisomes, FADH2 is not taken to ETC that generate ATP, rather, FADH2 is used to make H2O2 * catalase decompose H2O2 into H2O and O2, dissipating heat * for plants, normal FA catalysis occur in peroxisome rather than mitochondria ### 8. ketone bodies ![](https://i.imgur.com/xQrFcFB.png) ![](https://i.imgur.com/hcQg9Vl.png) ![](https://i.imgur.com/EMNOzK8.png) * acetone, acetoacetate and 3-hydroxybutyric acid are called ketone bodies * the former 2 possess a carbonyl group, the latter 2 are not ketone but carboxylic acid * ketone bodies are water suluable so that it can be seen as a transporatble form of FA (3mg/mL in human blood) #### synthesis of ketone body >* the reaction occur in **mitochondrial matrix of liver cell** >* amino acid, FA, glycolysis can all generate acyl-CoA >* 2 acyl-CoA binds together, making acetoacetyl-CoA >* add another acyl-CoA on the third carbon, making 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) >* HMG-CoA decompose, generating 1 acyl-CoA and 1 **acetylacetate** > >* by oxidizing the carboxyl group, acetylacetate turn into acetone >* by hydrogenating the carbonyl group, acetylaccetate turn into beta-hydroxylbutyrates > >|reaction|input|output|enzyme| >|:-:|:-:|:-:|:-:| >|1|2acyl-CoA|acetylacetyl-CoA|thiolase| >|2|acetylaccetyl-CoA, acyl-CoA|HMG-CoA|HMG-CoA synthase| >|3|HMG-CoA|acetoacetate, acyl-CoA|HMG-CoA lyase| #### use of ketone bodies >in muscle or other peripheral tissues, ketone bodies reconverse to acyl-CoA and join the TCA cycle and generate ATP #### diseases >ketosis induced acidosis: the pH value is too low when ketone bodies level rise, which may lead to coma or even death >type I diabetes: starving cells turn to glucogenesis or fat/protein catabolism excessive glucogenesis **depletes OAA**, which is essential for TCA cycle after glucolysis, excessive acyl-CoA had no choice but turn into ketone bodies as a result, acetone can be detected on breath ## wk3. lipid biosynthesis ### 1. synthesis versus catabolism ||synthesis|catabolism| |:-:|:-:|:-:| |when|after carbohydrate-rich meal|in starvation| |hormonal state|high insulin/glucagon ratio|high glucagon/insulin ratio| |activator|citrate|| |inhibitor|palmityl-CoA (or other fatty acyl-CoA) --> ACC|malonyl-CoA --> carnitine acyltransferase| |where (organ)|liver|liver and muscle| |where (cellular)|cytosol|mitochondria| |transmembrane carrier|citrate (M to C)|camitine (C to M)| |required coenzyme|NADPH|NAD+, FAD| |essential midproduct|Acyl carrier protein (ACP)|CoA| |product|palmitate, CO2|acyl-CoA| |isomer|D-isomer|L-isomer| ### 2. material for synthesis #### source of material >(citrate and pyruvate can pass through the inner membrane of mitochondria) >* excessive acyl-CoA get into TCA cycle, become citrate and **get to cytosol** >* citrate can regenerate **acyl-CoA** (citrate-malate-pyruvate shuttle) >* citrate ---ATP citrate lyase---> OAA >* OAA ---malate dehydrogenase---> malate (cost: 1NADH) >* malate ---malic enzyme---> pyruvate + CO2 (yeild: **1NADPH**) #### malonyl-CoA >is acyl-CoA acutually the material for FA syn.? >yes, and no. > >in first place, acyl-CoA should turn into **malonyl-CoA** which actually participate in the reaction > >acyl-CoA + CO2 ---> malonyl CoA (cost: 1ATP) >![](https://i.imgur.com/eQ8j6M4.png) #### acyl-CoA carboxylase >this **irreversible** reaction (**comitted** step) requires acyl-CoA carboxylase (ACC), which is the **rate-controlling** enzyme of FA syn. > >in bacteria: >* ACC is composed of 3 different proteins >(1) biotin carrier (2) biotin carboxylase (3) transcarboxylase > >in eukaryotes: >* ACC is composed of 2 identical peptides, which is **inactive** in **dimer (or protomer)** form but **active** in **polymer** form >* ACC is activated by the material, citrate (by phosphorylation at Pi-S1200); supress by the product, palmitoyl-CoA (allosteric feedback inhibition or phospholation on protein) >![](https://i.imgur.com/7oCKo8J.png) ### 3.steps of biosynsthesis #### step 1: condensation >|material|enzyme|product| >|-|-|-| >|malonyl-CoA|--MAT-->|malonyl-ACP| >|acyl-CoA|--MAT-->|acyl-ACP| >|malonyl-ACP + acyl-ACP|--KS-->|acetoacetyl-ACP + CO2 + ACP-SH| > >in the reaction, acyl-ACP cleave ACP >malonyl-ACP oxidize its carboxyl group, adding to acyl-ACP (and make CO2) > >MAT: **m**alonyl/**a**cyl-CoA-ACP **t**ransacylase >KS: beta-**k**etoacyl-ACP-**s**ynthase #### step 2: reduction >|material|enzyme|product| >|-|-|-| >|acetoacetyl-ACP|--KR-->|beta-hydrobutyryl-ACP| > >cost: 1NADPH >in the reaction, the carbonyl group (C=O) is reduced into hydroxyl group (C-OH) > >KR: beta-**k**etoacyl-ACP-**r**eductase #### step 3: dehydration >|material|enzyme|product| >|-|-|-| >|beta-hydrobutyryl-ACP|--DH-->|alpha,beta-transbutenoyl-ACP| > >in the reaction, a water is removed and a double bond is formed > >DH: ~ **d**e**h**ydrase #### step 4: reduction >|material|enzyme|product| >|-|-|-| >|alpha,beta-transbutenoyl-ACP|--ER-->|butyryl-ACP| > >cost: 1NADPH >in the reaction, 2 hydrogen is added, reducing the double bond > >ER: **e**noyl-ACP-**r**eductase >![](https://i.imgur.com/hh9R5DK.png) #### calculation >a 16C palmitic acid requires: >acyl-CoA to malonyl-CoA: -1ATP (x7) >adding a malonyl-CoA to the chain: -2NADPH (x7) > >total: 7ATP + 14NADPH >byproduct: 7CO2 ### 4.FA enlongation and desaturation #### elongation > the common product of FA syn. is **palmitate (16:0)**, which is synthesized in **cytosol** > larger FA is synthesized in **ER** > the enlongation steps are similar to normal biosynthesis, but the energy source of **step 2** is **NADH** #### unsaturation >e.g., from steric acid (18:0) to oleic acid (18:1, omega-9) >to form a double bond (reduction), it requires electron from co-enzymes >electron passed on from: >**NADH** ---> FADH2 ---> cytochrome b5(reduced) ---> **desaturase (Fe2+)** ---> stearoyl-CoA (omega-9 carbon) >mammals cannot certain kinds of FA since we don't have certain elongation/unsaturation enzymes >those which we cannot synthesized are called "essential FA" ### 5. regulation #### [ACC regulation](https://hackmd.io/_FbNZi9-S3GETj3oe-aCHw?view#acyl-CoA-carboxylase) >acyl-CoA carboxylase is the comitted step in FA syn. >citrate activates ACC and palnityl-CoA inhibit it #### carnitine acyltransferase >both palmityl-CoA and malonyl-CoA can block it, thus stopping beta-oxidation >(when cell is nourished, FA is synthesized and thus beta-oxidation is not favoured) #### hormone regulation >glucagon can activate **protein kinase** via **cAMP** >insulin can activate phosphodiesterase, tuning cAMP to AMP, thus stopping the following reaction > >PKA activate **TG lipase** and **inhibit ACC** >i.e., PKA endorse FA degration and inhibit FA synthesis >(protein kinase (active) is shortened as PKA) ### 6. complex lipids synthesis #### syn. of TG >the reaction in **hepatocyte**: > >glycerol >--- glycerokinase---> glycerol-3-phosphate (G3P,磷酸甘油醛) >--- G3P acyltransferase---> 1-acyl-G3P (MAG,磷酸化單酸甘油酯) >--- ~ acyltransferase---> phosphatidic acid (PA, 磷脂酸,磷酸化雙酸甘油酯) >--- ~ phosphatase---> 1,2-diacylglycerol (DAG,雙酸甘油酯) >--- ~ acyltransferase---> triacylglycerol (TG,三酸甘油酯) >other pathway (in **adopocyte**): >glycolysis ---> DHA-phosphate >--- 1NADH---> **G3P** >or >--- acyltransferase---> 1-acyl-DHA-phosphate >--- 1NADPH---> **1-acyl-G3P** >some facts >* 75% of FA that released by lipolysis is reesterfied to form TG >* hepatocytes can synthesize TG without glucose (by using glycerol), >but adopocytes cannot #### syn. of [phospholipid](https://hackmd.io/_FbNZi9-S3GETj3oe-aCHw?view#3Glycerophospholipids) >review of phospholipids >* phospholipid can be categorized by the func. group attach to phophate, the simplest phospholipid is phosphatidic acid >* PA --- ~ phosphatase---> DAG >* DAG can be turned into PC, PE, and TG (see above) >syn. of other phospholipids >* the nucleotide **CDP** can carry the func. group that add to DAG, **giving out a phosphate and the func. group** >* the enzyme required to make PC or PE names after the product >e.g., DAG + CDP-choline ---> phosphotidylcholine >the enzyme is called 1,2-diacylglycerol phosphocholine transferase >(1,2-diacylglycerol = phosphotidyl) >* cardiolipin: (FA)2-glycerol-Pi-glycerol-(FA)2 >* cardolipin is the major lipid of Mt. and it has an important role in ETC >syn. of spingolipids >* palmytoyl-CoA + serine ---> ceramide (the reaction consume 1NADPH) >* after synthesizing ceramide, addition on head group and addition of suagr make the variety of spingolipids >* the sugar attach to ceramide is carried by UDP >syn. of eicosamoid >* eicosnoid is the most potent signalling compound in human body >* thus, it produced in very small amount and has very short half-life >* PG, TX, LT, are synthesized from **unsaturated fatty acids**, have 3-5 **double bonds**, and are most common **arachidonic acids** >* PG and TX use COX (cyclooxygenase), while LT use lipoxygenase >* anti-inflammatory drugs: block PG production corticosteroids ---> PLA2; NSAID ---> COX 1&2 >NSAID >|act on|irreversible|reversible| >|-|-|-| >|COX 1&2|aspirin (serine acylation)|acetaminophen, ibuprofen| >|COX 2 only|celebrex|| > >COX1 func. >* protect stomach lining >* decrease fever >* clot > >COX2 func. >* trigger pain and inflammation >**thus, drugs that only act on COX2 have less side effects** ## wk4.cholesterol synthesis ### 1.cholesterol 101 >structure of cholesterol > >![](https://i.imgur.com/aSmAVm6.png) ![](https://i.imgur.com/S12MNLv.png) >some facts about cholesterol >* member of membrane >* precursor of bile salt, steriod hormone, Vit.D >* mainly produced in ER of hepatocytes >* the only material is acyl-CoA >source of cholesterol >* de novo syn. >* diet >* syn. in extrahepatic tissues >outlet of cholesterol >* stored in lipid droplet (as chol. ester) >* secretion of HDL & VLDL to blood (as chol. ester) >* release to bile >* conversion to bile salt/acids ### 2.synthesis of cholesterol #### DPP (5C) > 2acyl-CoA > ---thiolase---> acetoacetyl-CoA > ---HMG-CoA synthase---> HMG-CoA > --- ~ reductase, 2NADPH---> mevalonic acid > ---3ATP---> IPP + **CO2** > --- ~ transferase---> DPP #### squalene (30C) > IPP + DPP = GPP > GPP + DPP = FPP > FPP + FPP = squalene > (using squalene synthase, 1NADPH) #### cholesterol (27C) > squalene > --- ~ monoxygenase, 1NADPH--->squalene-2,3-epoxide (氧雜環) > --->--->---> cholesterol ![](https://i.imgur.com/ceGXCwe.png) ### 3.regulation of chol. syn. #### HMG-CoA reductase >* phosphorylation: the patheway use cAMP as the messenger from hormone to protein kinase >(this kinase is called adenosine monophosphate-activated protein, or **AMPK**) >* halflife: the higher chol. level, the lower halflife of the reductase >* genetic expression: the higher chol. level, the lower mRNA level > >|promote|inhibit|-| >|-|-|-| >|insulin|glucagon, AMPK (phosphorylation), oxysterol >(proteolysis)|-| #### sterol regulatory elements-binding protein >* when sterol level is high, protein insig binds to sec on ER membrane >* when sterol level **goes down**, sec binds to SCAP-SREBP and escort the complex to Golgi apparatus >* in Golgi apparatus, regualrtory domain of SREBP is released >* the regulatory domain get into nucleus and promote lipid syn. enzymes >* the name of SREBP indicates that it contain the regulatory domain >* SCAP, or SREBP cleavage activating protein, promote the release of regulatory domain in Golgi apparatus #### acyl-CoA:cholesterol acyl transferase >* when chol. level goes up, it promote ACAT >* ACAT turns chol. into chol. esters #### drug control >* statins: inhibit (competitively) HMG-CoA to slow down de novo syn. ![](https://i.imgur.com/pmfEO1r.png) ### 4.bile salts 101 >* act as emusifier to dietary lipids >* synthesized in the liver and stored in gallbladder >* enterohepatic circulation: bile salts in GI tract reabsorbed to the liver >* excretion in feces as a way to do with **excessive chol.** >* only bile salts, not acid, are found in the bile ### 5.syn. of bile salts >* chol./bile acid conjugated with Glycine or Taurine by amide linkage >* bile salts are more likely to inoized beacuse of the COO- and SO3- >* bile salts would deconjugate and dehydr oxylate in intestine, losing added amino acid and OH >* bacteria can help to convert primary to secondary bile acids or regenerating bile acids primary and secondary bile acids ![](https://i.imgur.com/xyrP34N.png) ### 6.cholelithiasis >* the liver secrete bile salts with phospholipid to the gallbladder >* if chol. is excessive, it may percipitate in the gallbladder and cause cholelithiasis ### 7.steroid hormone >glands that secrete steroid hormone >|gland|hormone| >|-|-| >|adrenal cortex|aldosterone (mineralcorticoids), cortisol (glucocorticoids), androgens [from outer to inner]| >|testis|testosterone| >|ovaries|estrogens, progesterone| >* steroid hormone are derived from chol. and differ only in the ring structure and side chain attached to it >* these gland gain chol. from LDL by endocytosis >* adreno cortical cells can synthesize chol. itself >* the rds in the biosynthesis of steroid hormone involve **cytochrome P450 side chain cleavage (P450 scc) enzyme** >* testosterone can promote anabolism, so it is prohibited to atheletes ### 8.Vit. D >* Vit. D3 (cholecalciferol) synthesized in skin when expose to sunlight >* cholecalciferol convert to calcidiol in liver >* calcidiol convert to calcitriol in kidney (active form) ![](https://i.imgur.com/iISYJ0U.png) ## wk4. lipid transport ### 1.lipoprotein 101 >* lipoprotein consist of lipids and proteins (as follow) ![](https://i.imgur.com/LRAaZ6t.png) > >* the structure of lipoprotein are as follow, with hydrophilic side of proteins, phospholipids and chol. towards out >![](https://i.imgur.com/qpTsWdw.png) ### 2.diffferent type of lipoprotein >* particle size: chylomicron > VLDL > VDL > HDL >* TG (%): chylomicron > VLDL > VDL > HDL >* density: chylomicron < VLDL < VDL < HDL >* protein: chylomicron < VLDL < VDL < HDL >|lipoprotein|lipid of the greatest %|apolipoprotein|syn. site| >|-|-|-|-| >|chylomicron (CM)|TG|B-48, E, C-II, A|intestinal mucosal| >|very low density lipoproteins (LVDL)|TG|B-100, E, C-II|liver| >|low density lipoproteins (LDL)|chol.|B-100, ...|VLDL circulation| >|high density lipoproteins (HDL)|chol.|E, C, A (mainly A)|peripheral cells| >fate of chylomicron >* when CM enter vessels, HDL pass its **apo-C-II and apo-E** to CM >* tissues such as adipocyte absorb and degrade some of the TG in CM and thus, apo-C-II goes back to HDL >* since TG is absorbed, proportion of chol. and chol. ester rise in CM >* the CE-rich CM remnant bind through apo-E on hepatocyte >* summary, peripheral tissues get TG, liver cells get chol. >fate of VLDL >* the fate of VLDL is very much that of CM >* after TG absorbing, apo-B-100 binds to extrahepatic tissue and be endocytosed >fate of LDL >* LDL derived from VLDL, it can send chol. from liver to others >* LDL is chol.-rich and can be absorbed by cells via receptor-mediated endocytosis >* after endocytosis, receptor is sent back to cytomembrane >* diferent cells have different ways of use of chol., e.g., cell membrane, steroid hormone (hepatocytes) > >* regulation: when the cell has enough or excessive amount of chol., the **oxysterol will inhibit endocytosis**; >meanwhile, chol. promotes ACAT and turning it into chol. ester, and chol. inhibit HMG-reductase to decrease chol. level >* disease: familial hypercholesterolemia = defect in LDL receptor (cell can't absorb LDL so that it remain in vessels) atherosclerosis = macrophage take in LDL, making foam cell, which will hurt endothelium cells... >fate of HDL >* lecithin-chol. acyl transferase (LCAT) can esterify chol. >* the enzyme apo-A1 is associated with the activity of LCAT >* cholesteryl ester transfer protein (CETP) can exchage CE for TG with VLDL, so that HDL and VLDL gradually become LDL >* summary, HDL collects chol. from peripheral tissues, exchanges chol. for TG with VLDL, and VLDL carries chol. back to the liver >* the func. of HDL: uptake of chol., reservoir of apo., esterification of chol. ## wk.5 amino acid metabolism ### 1. nitrogen metabolism #### dietary proteins lyase >|organ|precursor|activator|enzyme|func.| >|-|-|-|-|-| >|stomach|pepsinogen|HCl|pepsin|15% protein ---> peptide| >|pancreas|trypsinogen|enterokinase|trypsin|polypeptide ---> di, tripeptide| >|pancreas|chymotrysinogen proelastase|trypsin|chymotrypsin elastase|~ ---> di, tripeptide, amino acid| >|pancreas|procarboxypeptidase|trypsin|carboxypeptidase A&B|~ ---> di, tripeptide, amino acid| >|intestine|-|-|aminopeptidase|~ ---> di, tripeptide, amino acid| ### 2.protein degradation #### ATP-independent/dependent protein degradation >lysosome: independent >26S proteasome: dependent (attach to ubiquitin >the 26S proteasome is the "garbage disposer" in a cell #### three enzymes related to proteasome >the 3 enymes are: >* E1: ubiquitin-activating enzyme >* E2: ubiquitin-conjugating enzyme >* E3: ubiquitin ligase >the steps: >* E1 bind to a ubiquitin >* E1 pass ubiquitin to E2 >* E3 bind to E2-ubiquitin >* E3-E2-ubiquitin bind to target protein >* one target protein can bind to many ubiquitin (polyubiquitination) >* after the target get into proteasome, ubiquitin is recycled >thus the ubiquitin is called the "death tag" (2004 Nobel ### 3. amino acid degradation #### some facts >* AA can be seprated into 2 parts: carbon skeleton and amino group >* seperate the two parts requires **anino transferase** (12 enzyme for 20 AA) >* the carbon skeleton tunr into pyruvate and subsequently become material for FA or carbohydrates >* in low insulin/glucagon ratio, >* AA can be turned into bases of nucleotides >* AA can also be turned into ammonia via **urea cycle** #### example (memorize) >* the carbon chain resdue can be turned into pyruvate, acyl-CoA, acetoactate or acyl-CoA and members of TCA cycle >* 3C alanine ---> pyruvate >* 4C aspartate ---> oxaloacetate (OAA) >* 5C glutamate ---> alpha-ketoglutarate >* all the products can be generized as "alpha-keto acid" #### glucogenic and ketogenic >* those which generate TCA cycle participants or pyruvate are glucogenic; those which generate ketone bodies are ketogenic > >|glutogenic|both|ketogenic| >|-|-|-| >|Ala, Arg, Asp, Asn, Cys, Met, Glu, Gln, Gly, His, Pro, Ser, Thr, Val|Tyr, Iso, Phe, Try|Leu, Lys| > >|family|members|product| >|-|-|-| >|C3|Ala, Ser, Cys, Gly, Thr, Trp|pyruvate| >|C4|Asp, Asn|OAA| >|C4|Asp, Phe, Tyr|fumarate|alpha-ketoglutarate| >|~|Ile, Met, Val|succinyl-CoA| >|~|Ile, Leu, Thr|acyl-CoA| >|~|Leu, Lys, Phe, Tyr, Trp|acetoacetate| #### branched and non-branched >* nonbranched chain AA (NBCAA) undergo transaminonation in **liver** >* branched chain AA (e.g, Leu, Ile, Val), muscle >* muscle must remove the amino group of BCAA before releasing them, but not NBCAA > >* the reaction is reversable, menaing **AA synthesis also use this pathway** >* **pyridoxal-5'-phosphate (PLP)** is an coenzyme that present in all aminotransferase >* PLP is the active form of **Vit. B6** #### futher about BCAA catabolism >* **Leu, Ile, Val** are branched chain amino acids >* in muscular cells, the amino group of BCAA is transferred to glutamate, making **Ala** and goes to the **liver**, or making **glutamine** and goes to **kidney** > >![](https://i.imgur.com/Ttd8N1O.png) >* after transferring the amino group, alpha-keto acid is can be turned into acyl-CoA >* such reaction requires **branched chain ketoacid dehydrogenase (BCKD)**, which is the **rds** of BCAA catabolism >* defectibe BCKD leads to **maple syrup urine disease (MSUD)** #### maple syrup urine disease (MSUD) >* excessive BCAA in bloodstream, leading to maple syrup-esque urine >* excessive ketoacids in blood, causing **ketoacidosis** >* encephalopathy and coma >* the treatment is mostly dietary control (not consuming BCAA) ### 4. urea cycle >in nitochondria #### step 1 carbamoyl phosphate syn. >2 HCO3- ---CPS I, **2ATP**---> carbamoyl phosphate >![](https://i.imgur.com/jsBXdIc.png) #### step 2 citrulline syn. >carbamoyl phosphate + ornithine ---OTC---> citrulline >in cytosol #### step 3 argininosuccinate syn. citrulline + aspartate ---ASS---> arigininosuccinate #### step 4 cleavage of argininosuccinate argininosuccinate ---> argnine + fumarate #### step 5 regeneration of ornithine arginine + H2O ---> **urea + ornithine** #### note >* the two nitrogen in urea is from **carbamoyl and aspartate** >* the carbon of urea is from **carbamoyl** >* urea is then sent to live to be turned into urine ### 5. regulation of urea cycle #### positive >* N-acylglutamate: allosteric, CPS I >* glucagon/cortisol: gene, transcription #### negative >* acidosis: allosteric, pH of blood (the lower the slower) >* decreased beta-oxidation: less ATP, less urea cycle ### 6. inherited disease link to AA metabolism >|disease|correlated AA|description|symptoms| >|-|-|-|-| >|albinism|Tyr|melanin syn. from Tyr|白化症:無法由Tyr合成黑色素| >|alkaptonuria (AKU)|Tyr|Tyr degradation|黑尿症:放在空氣中一陣子就變黑、關節炎、發育遲緩| >|homocystinuria (Marfan syndrome)|Met|Met degradation (turn into hemocystine rather than Cys)|骨骼發育問題、智障| >|MSUD|BCAAs|BACC dehydrogenation|嘔吐、智障、早夭| >|phenylketonuria (PKU)|Phe ---> Tyr|Phe dehydrogenation|嘔吐、智障,不可以吃代糖| ## wk7. Heme ### 1. homoglobin 101 >* the core of alpha or beta chain, heme group is made of porphyrin group and an iron ion >* porphyrin can link to many other metal ion to function differently >* a porphyrin has 4 acetate groups and 4 propionyl groups, with which we can catagorize heme > >* hemes are synthissed in **bone marrow (85%) and liver (15%) >* material of heme includes **succinyl-CoA and glycine ### 2.biosynthesis of porphyrin > 8 steps, the fist step in mitochondria, then 4 steps in cytosol, the rest in mitochondria #### step 1: ALA >1succinyl-CoA + 1Gly ---ALA synthase---> >1omega-aminolevulinic acid (ALA) + CO2 > >the reaction release a CO2 #### step 2: BPG >2ALA ---ALA dehydratase---> 1PBG >PBG is the intermediate of one of the 4 pyrrole ring of heme > >the reaction is sensitive to heavy metal poisoning #### step 3: HMB >4PBG ---HMB synthase---> 1HMB > >the reaction forms a chain of 4 PBG without closing the ring #### step 4: uroporphyrunogen >1HMG ---> uroporphyrunogen > >there are many kinds of porphyrin, type I has symmatric P, A group arrangement while type III don't #### step 5: coproporphyrinogen >uroporphyinogen --- ~ decarboxylase--- > coproporphyrinogen > >losing 1 CO2 at each side while closing the ring >acetate ---> methyl #### step 6: photoporphyrinogen >coproporphyrinogen --- ~ oxidase---> photoporphyrinogen > > propionate ---> vinyl #### step 7: activation of photoporphyrinogen >photoporphyrinogen ---> photoporphyrin #### step 8: addition of iron >Fe 3+ cna link to an anion via ionic bond >if the anion is Cl-, the whole complex is called "hemin" >if OH-, hemeatin ###### tags: `midterm`, `biochemistry`

    Import from clipboard

    Paste your markdown or webpage here...

    Advanced permission required

    Your current role can only read. Ask the system administrator to acquire write and comment permission.

    This team is disabled

    Sorry, this team is disabled. You can't edit this note.

    This note is locked

    Sorry, only owner can edit this note.

    Reach the limit

    Sorry, you've reached the max length this note can be.
    Please reduce the content or divide it to more notes, thank you!

    Import from Gist

    Import from Snippet

    or

    Export to Snippet

    Are you sure?

    Do you really want to delete this note?
    All users will lose their connection.

    Create a note from template

    Create a note from template

    Oops...
    This template has been removed or transferred.
    Upgrade
    All
    • All
    • Team
    No template.

    Create a template

    Upgrade

    Delete template

    Do you really want to delete this template?
    Turn this template into a regular note and keep its content, versions, and comments.

    This page need refresh

    You have an incompatible client version.
    Refresh to update.
    New version available!
    See releases notes here
    Refresh to enjoy new features.
    Your user state has changed.
    Refresh to load new user state.

    Sign in

    Forgot password

    or

    By clicking below, you agree to our terms of service.

    Sign in via Facebook Sign in via Twitter Sign in via GitHub Sign in via Dropbox Sign in with Wallet
    Wallet ( )
    Connect another wallet

    New to HackMD? Sign up

    Help

    • English
    • 中文
    • Français
    • Deutsch
    • 日本語
    • Español
    • Català
    • Ελληνικά
    • Português
    • italiano
    • Türkçe
    • Русский
    • Nederlands
    • hrvatski jezik
    • język polski
    • Українська
    • हिन्दी
    • svenska
    • Esperanto
    • dansk

    Documents

    Help & Tutorial

    How to use Book mode

    Slide Example

    API Docs

    Edit in VSCode

    Install browser extension

    Contacts

    Feedback

    Discord

    Send us email

    Resources

    Releases

    Pricing

    Blog

    Policy

    Terms

    Privacy

    Cheatsheet

    Syntax Example Reference
    # Header Header 基本排版
    - Unordered List
    • Unordered List
    1. Ordered List
    1. Ordered List
    - [ ] Todo List
    • Todo List
    > Blockquote
    Blockquote
    **Bold font** Bold font
    *Italics font* Italics font
    ~~Strikethrough~~ Strikethrough
    19^th^ 19th
    H~2~O H2O
    ++Inserted text++ Inserted text
    ==Marked text== Marked text
    [link text](https:// "title") Link
    ![image alt](https:// "title") Image
    `Code` Code 在筆記中貼入程式碼
    ```javascript
    var i = 0;
    ```
    var i = 0;
    :smile: :smile: Emoji list
    {%youtube youtube_id %} Externals
    $L^aT_eX$ LaTeX
    :::info
    This is a alert area.
    :::

    This is a alert area.

    Versions and GitHub Sync
    Get Full History Access

    • Edit version name
    • Delete

    revision author avatar     named on  

    More Less

    Note content is identical to the latest version.
    Compare
      Choose a version
      No search result
      Version not found
    Sign in to link this note to GitHub
    Learn more
    This note is not linked with GitHub
     

    Feedback

    Submission failed, please try again

    Thanks for your support.

    On a scale of 0-10, how likely is it that you would recommend HackMD to your friends, family or business associates?

    Please give us some advice and help us improve HackMD.

     

    Thanks for your feedback

    Remove version name

    Do you want to remove this version name and description?

    Transfer ownership

    Transfer to
      Warning: is a public team. If you transfer note to this team, everyone on the web can find and read this note.

        Link with GitHub

        Please authorize HackMD on GitHub
        • Please sign in to GitHub and install the HackMD app on your GitHub repo.
        • HackMD links with GitHub through a GitHub App. You can choose which repo to install our App.
        Learn more  Sign in to GitHub

        Push the note to GitHub Push to GitHub Pull a file from GitHub

          Authorize again
         

        Choose which file to push to

        Select repo
        Refresh Authorize more repos
        Select branch
        Select file
        Select branch
        Choose version(s) to push
        • Save a new version and push
        • Choose from existing versions
        Include title and tags
        Available push count

        Pull from GitHub

         
        File from GitHub
        File from HackMD

        GitHub Link Settings

        File linked

        Linked by
        File path
        Last synced branch
        Available push count

        Danger Zone

        Unlink
        You will no longer receive notification when GitHub file changes after unlink.

        Syncing

        Push failed

        Push successfully